Capsule Type of Streptococcus pneumoniae Determines Growth Phenotype

The polysaccharide capsule of Streptococcus pneumoniae defines over ninety serotypes, which differ in their carriage prevalence and invasiveness for poorly understood reasons. Recently, an inverse correlation between carriage prevalence and oligosaccharide structure of a given capsule has been described. Our previous work suggested a link between serotype and growth in vitro. Here we investigate whether capsule production interferes with growth in vitro and whether this predicts carriage prevalence in vivo. Eighty-one capsule switch mutants were constructed representing nine different serotypes, five of low (4, 7F, 14, 15, 18C) and four of high carriage prevalence (6B, 9V, 19F, 23F). Growth (length of lag phase, maximum optical density) of wildtype strains, nontypeable mutants and capsule switch mutants was studied in nutrient-restricted Lacks medium (MLM) and in rich undefined brain heart infusion broth supplemented with 5% foetal calf serum (BHI+FCS). In MLM growth phenotype depended on, and was transferred with, capsule operon type. Colonization efficiency of mouse nasopharynx also depended on, and was transferred with, capsule operon type. Capsule production interfered with growth, which correlated inversely with serotype-specific carriage prevalence. Serotypes with better growth and higher carriage prevalence produced thicker capsules (by electron microscopy, FITC-dextran exclusion assays and HPLC) than serotypes with delayed growth and low carriage prevalence. However, expression of cpsA, the first capsule gene, (by quantitative RT-PCR) correlated inversely with capsule thickness. Energy spent for capsule production (incorporation of H3-glucose) relative to amount of capsule produced was higher for serotypes with low carriage prevalence. Experiments in BHI+FCS showed overall better bacterial growth and more capsule production than growth in MLM and differences between serotypes were no longer apparent. Production of polysaccharide capsule in S. pneumoniae interferes with growth in nutrient-limiting conditions probably by competition for energy against the central metabolism. Serotype-specific nasopharyngeal carriage prevalence in vivo is predicted by the growth phenotype.

[1]  A. Nelson,et al.  Capsule Enhances Pneumococcal Colonization by Limiting Mucus-Mediated Clearance , 2006, Infection and Immunity.

[2]  J. Yother,et al.  Mutations Blocking Side Chain Assembly, Polymerization, or Transport of a Wzy-Dependent Streptococcus pneumoniae Capsule Are Lethal in the Absence of Suppressor Mutations and Can Affect Polymer Transfer to the Cell Wall , 2007, Journal of bacteriology.

[3]  R. Morona,et al.  Tyrosine phosphorylation of CpsD negatively regulates capsular polysaccharide biosynthesis in Streptococcus pneumoniae , 2000, Molecular microbiology.

[4]  Julian Parkhill,et al.  Genetic Analysis of the Capsular Biosynthetic Locus from All 90 Pneumococcal Serotypes , 2006, PLoS genetics.

[5]  Jeremy S. Brown,et al.  The Streptococcuspneumoniae Capsule Inhibits Complement Activity and Neutrophil Phagocytosis by Multiple Mechanisms , 2009, Infection and Immunity.

[6]  J. Yother,et al.  Positive Correlation between Tyrosine Phosphorylation of CpsD and Capsular Polysaccharide Production in Streptococcus pneumoniae , 2003, Journal of bacteriology.

[7]  J. Takeda,et al.  New bronchoscopic microsample probe to measure the biochemical constituents in epithelial lining fluid of patients with acute respiratory distress syndrome , 2001, Critical care medicine.

[8]  K. Mühlemann,et al.  In vitro expression of the first capsule gene of Streptococcus pneumoniae, cpsA, is associated with serotype-specific colonization prevalence and invasiveness. , 2007, Microbiology.

[9]  J. Claverys,et al.  An rpsL Cassette, Janus, for Gene Replacement through Negative Selection in Streptococcus pneumoniae , 2001, Applied and Environmental Microbiology.

[10]  R. Giordano,et al.  Purification of capsular polysaccharide from Streptococcus pneumoniae serotype 23F by a procedure suitable for scale‐up , 2003, Biotechnology and applied biochemistry.

[11]  J. Galagan,et al.  Pneumococcal Capsular Polysaccharide Structure Predicts Serotype Prevalence , 2009, PLoS pathogens.

[12]  T. Kozel,et al.  Molecular architecture of the Cryptococcus neoformans capsule , 2004, Molecular microbiology.

[13]  K. Mühlemann,et al.  Capsule genes of Streptococcus pneumoniae influence growth in vitro. , 2007, FEMS immunology and medical microbiology.

[14]  P. Zucs,et al.  Distribution and Invasiveness of Streptococcus pneumoniae Serotypes in Switzerland, a Country with Low Antibiotic Selection Pressure, from 2001 to 2004 , 2006, Journal of Clinical Microbiology.

[15]  B. Spratt,et al.  Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. , 2004, The Journal of infectious diseases.

[16]  K R Anumula,et al.  High resolution and high sensitivity methods for oligosaccharide mapping and characterization by normal phase high performance liquid chromatography following derivatization with highly fluorescent anthranilic acid. , 1998, Glycobiology.

[17]  T. Bodmer,et al.  Nationwide surveillance of nasopharyngeal Streptococcus pneumoniae isolates from children with respiratory infection, Switzerland, 1998-1999. , 2003, The Journal of infectious diseases.

[18]  F. Kong,et al.  First report of putative Streptococcus pneumoniae serotype 6D among nasopharyngeal isolates from Fijian children. , 2009, The Journal of infectious diseases.

[19]  M. Lipsitch,et al.  Construction of Otherwise Isogenic Serotype 6B, 7F, 14, and 19F Capsular Variants of Streptococcus pneumoniae Strain TIGR4 , 2003, Applied and Environmental Microbiology.

[20]  K. Anumula,et al.  Carbohydrate composition analysis of glycoproteins using highly sensitive fluorescence detection methods. , 2002, Methods in molecular biology.

[21]  K R Anumula,et al.  Quantitative determination of monosaccharides in glycoproteins by high-performance liquid chromatography with highly sensitive fluorescence detection. , 1994, Analytical biochemistry.

[22]  J. Brewster,et al.  A simple micro-growth assay for enumerating bacteria. , 2003, Journal of microbiological methods.

[23]  E. Moxon,et al.  The role of bacterial polysaccharide capsules as virulence factors. , 1990, Current topics in microbiology and immunology.

[24]  K. Mühlemann,et al.  Serotype-specific invasiveness and colonization prevalence in Streptococcus pneumoniae correlate with the lag phase during in vitro growth. , 2006, Microbes and infection.

[25]  P. Andrew,et al.  Upper and Lower Respiratory Tract Infection by Streptococcus pneumoniae Is Affected by Pneumolysin Deficiency and Differences in Capsule Type , 2002, Infection and Immunity.

[26]  S. Hammerschmidt,et al.  Pneumococcal protein PavA is important for nasopharyngeal carriage and development of sepsis. , 2010, Molecular oral microbiology.

[27]  K. Mühlemann,et al.  Low-Level Resistance to Rifampin in Streptococcus pneumoniae , 2003, Antimicrobial Agents and Chemotherapy.

[28]  D. Musher,et al.  A brief history of the pneumococcus in biomedical research. , 1999, Seminars in respiratory infections.

[29]  P. Andrew,et al.  The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease. , 2010, Immunobiology.

[30]  Aras Kadioglu,et al.  Host Cellular Immune Response to Pneumococcal Lung Infection in Mice , 2000, Infection and Immunity.

[31]  D. Studer,et al.  A new approach for cryofixation by high‐pressure freezing , 2001, Journal of microscopy.

[32]  W. Graber,et al.  Differential extraction of proteoglycans from cartilage tissue matrix compartments in isotonic buffer salt solutions and commercial tissue-culture media. , 1986, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[33]  S. Lacks.  Integration efficiency and genetic recombination in pneumococcal transformation. , 1966, Genetics.